Abstract
Pharmacoeconomic analyses are increasingly used to help decision-makers assess the value of health interventions. This value assessment promotes the effective and affordable use of healthcare resources. Different frameworks used in pharmacoeconomic analyses, with a focus on common modeling methods, are discussed. The following pharmacoeconomic analyses are compared and contrasted: cost-of-illness analysis (COI), budget-impact analysis (BIA), cost-comparison analysis, cost-minimization analysis (CMA), cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-consequence analysis (CCA), and cost-benefit analysis (CBA). The commonly used modeling methods, including decision trees and Markov models, are compared.
| Original language | English |
|---|---|
| Title of host publication | Clinical Pharmacy Education, Practice and Research |
| Subtitle of host publication | Clinical Pharmacy, Drug Information, Pharmacovigilance, Pharmacoeconomics and Clinical Research |
| Editors | Dixon Thomas |
| Publisher | Elsevier |
| Chapter | 18 |
| Pages | 261-275 |
| Number of pages | 15 |
| ISBN (Electronic) | 9780128142769 |
| ISBN (Print) | 9780128142776 |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- Affordability
- Cost-effectiveness
- Evaluation
- Pharmacoeconomic analysis